INS and metabolic dysfunction-associated steatohepatitis: Thus, it will be imperative to assess whether altered activity of phosphatase or kinase enzymes, as the result of changing ROS levels, plays a pathogenic a role in worsening insulin sensitivity in NAFLD/NASH.